Pfizer Inc (PFE) - Biopharma Revenue (I:PIPFEBR)
57.19B USD for 2023
Level Chart
Basic Info
|
Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago. |
|
Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 57.19B |
| Latest Period | 2023 |
| Last Updated | Jan 31 2024, 08:41 EST |
| Next Release | Jan 31 2025, 08:30 EST (E) |
| Average Growth Rate | 21.17% |
| Value from 1 Year Ago | 98.99B |
| Change from 1 Year Ago | -42.23% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2023 | 57.19B |
| December 31, 2022 | 98.99B |
| December 31, 2021 | 79.56B |
| December 31, 2020 | 40.72B |
| December 31, 2019 | 38.01B |
| December 31, 2018 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
Basic Info
|
Pfizer Inc (PFE) - Biopharma Revenue is at a current level of 57.19B, down from 98.99B one year ago. This is a change of -42.23% from one year ago. |
|
Biopharma Revenue refers to the sales of these products to various markets and customers, including healthcare providers, governments, and patients. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 57.19B |
| Latest Period | 2023 |
| Last Updated | Jan 31 2024, 08:41 EST |
| Next Release | Jan 31 2025, 08:30 EST (E) |
| Average Growth Rate | 21.17% |
| Value from 1 Year Ago | 98.99B |
| Change from 1 Year Ago | -42.23% |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |